Printer Friendly

COMPANY INFORMATION
Theratechnologies Inc. 2310 boul Alfred-Nobel Montréal, QC H4S 2A4 Tel: (514) 336-7800 Fax: (514) 336-7242 Contact Name Aline Vandermeer Industry Biotechnology		Key Executives Yves Rosconi, CEO Luc Tanguay, CFO Discovers and develops therapeutic products that target unmet medical needs in commercially attractive specialty markets. The company's lead product candidate, a growth hormone-releasing factor (GRF) analogue called tesamorelin, has completed Phase III clinical trials for the treatment of HIV-associated lipodystrophy. Tesamorelin is also indicated for growth hormone deficient abdominal obesity and mild cognitive impairment. The company is also developing molecules to treat acute renal failure.
FP ADVISOR COVERAGE Theratechnologies Inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Investor Reports • Ordering FP Products		TOP INDUSTRY PLAYERS Biotechnology Company Name Revenue ($000s)  Atrium Innovations Inc. 309,546 Angiotech Pharmaceuticals, Inc. 302,251 QLT Inc. 132,457 Oncothyreon Inc. 42,678 AEterna Zentaris Inc. 41,056 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/TH $4.74 $5.50 $1.18 n.a. n.a. n.a. 1.78 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 215,573 n.a. $-0.43 Aug. 31/09 279.2% -18.36% 16.59% $286,284
ANNUAL FINANCIALS Periods ended: 12m Nov. 30/08 12m Nov. 30/07 12m Nov. 30/06 $000s $000s $000s Operating revenue 214 638 197 Net income (48,953) (37,588) (25,861) Total assets 54,144 74,590 50,968 $ $ $ Earnings per share* (0.85) (0.71) (0.60) % % % Return on equity (86.70) (68.06) (55.33)   * Common
TRAILING 12-MONTH VALUES Periods ended: Aug. 31/09 Aug. 31/08 $000s $000s Operating revenue 15,848 740 Net income (25,800) (43,792) $ $ Earnings per share (0.44) (0.78)

COMPANY NEWS

Results for 'Theratechnologies Inc.' from past 30 days: 1 hit. Labopharm may be the win Canada's biotech sector needs; 'Great keypoint' National Post - Fri Feb 5 2010 - 558 words (Links are to articles.)